Clinical Evaluation of Ultrasonic Hydration Monitor for Infants
IHM-01
Study of Ultrasonic Hydration Monitor for Neonatology and Pediatric Children and Infants and/or Children up to Age 3 Years Old With Diarrhea
2 other identifiers
observational
42
1 country
1
Brief Summary
Study will verify ability of infant Hydration Monitor (IHM) to assess changes of hydration status in newborns and infants by means of ultrasound velocity measurements through muscle tissues. Changes of tissue hydration will be followed during first days of life in newborns and in acute diarrhea in small children during re-hydration therapy. Weighting and clinical dehydration symptoms will be used as controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 28, 2011
CompletedFirst Posted
Study publicly available on registry
November 30, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedMarch 31, 2014
March 1, 2014
11 months
November 28, 2011
March 28, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assess the ability of IHM to measure changes of hydration status ni newborn and infants
Infants and small children diagnosed with diarrhea or presenting to the hopsital with diseases known to cause dehydration are eligible
1 week to several months
Eligibility Criteria
Newborns from 1 to 7 days Small children from 1 month to 3 years old
You may qualify if:
- Newborns from 1 to 7 days old,
- Health infants from 1 month to 3 years old,
- Any ethnicity,
- Male or female,
- Infants with diarrhea,
- Acute gastroenteritis,
- Diarrhea and/or vomiting,
- Suspected dehydration
You may not qualify if:
- Congenital heart disease,
- Renal failure,
- Chronic liver disease,
- Chronic lung disease,
- Inflammatory bowel disease,
- Immune deficiency,
- Severe malnutrition,
- Any external damage to skin of leg,
- Infants and Children whose parents refuse permission to be included
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Artann Laboratorieslead
- Bill and Melinda Gates Foundationcollaborator
Study Sites (1)
Children Clinical University Hospital (CCUH) of the Riga Stradinsh University (RSU)
Riga, LV-1004, Latvia
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dace Gardovska, Dr. Med.
Head of Pediatrics, CCUH RSU
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2011
First Posted
November 30, 2011
Study Start
November 1, 2011
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
March 31, 2014
Record last verified: 2014-03